These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26560854)

  • 1. The role of hypoxia in pancreatic cancer: a potential therapeutic target?
    Erkan M; Kurtoglu M; Kleeff J
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):301-16. PubMed ID: 26560854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.
    Onishi H; Katano M
    World J Gastroenterol; 2014 Mar; 20(9):2335-42. PubMed ID: 24605030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting hypoxic tumor microenvironment in pancreatic cancer.
    Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
    J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the hypoxia pathway to treat pancreatic cancer.
    Erickson LA; Highsmith WE; Fei P; Zhang J
    Drug Des Devel Ther; 2015; 9():2029-31. PubMed ID: 25897209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
    Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
    Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer.
    Shah VM; Sheppard BC; Sears RC; Alani AW
    Cancer Lett; 2020 Nov; 492():63-70. PubMed ID: 32822815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
    Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
    Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
    Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
    Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
    Li W; Cao L; Chen X; Lei J; Ma Q
    Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers.
    Zhang H; Cao K; Xiang J; Zhang M; Zhu M; Xi Q
    Cancer Lett; 2023 Sep; 571():216345. PubMed ID: 37558084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
    Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
    Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Adaptation System to Avoid Apoptosis
    Owada S; Ito K; Endo H; Shida Y; Okada C; Nezu T; Tatemichi M
    Anticancer Res; 2017 Sep; 37(9):4927-4934. PubMed ID: 28870914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
    Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
    Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
    Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
    Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia.
    Chintamaneni PK; Pindiprolu SKSS; Swain SS; Karri VVSR; Nesamony J; Chelliah S; Bhaskaran M
    Cancer Lett; 2024 Apr; 588():216782. PubMed ID: 38453046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma.
    Babiker HM; Riaz IB; Shah SR; Von Hoff DD; Borad MJ
    Anticancer Drugs; 2017 Feb; 28(2):127-132. PubMed ID: 27685167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia: a barricade to conquer the pancreatic cancer.
    Tan Z; Xu J; Zhang B; Shi S; Yu X; Liang C
    Cell Mol Life Sci; 2020 Aug; 77(16):3077-3083. PubMed ID: 31907561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia.
    Zhu H; Wang D; Zhang L; Xie X; Wu Y; Liu Y; Shao G; Su Z
    Oncol Rep; 2014 Sep; 32(3):935-42. PubMed ID: 24994549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions].
    Cheng ZX; Sun B; Wang SJ; Zhou HX; Jia G; Kong R; Wang G; Jiang HC
    Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):446-51. PubMed ID: 22883954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.